Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.54 |
| ▸ | CTSB | P07858 | 1/20 | 0.47 |
| ▸ | ELANE | P08246 | 1/20 | 0.47 |
| ▸ | TOP1 | P11387 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 6/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.46 |
| ▸ | MAPT | P10636 | 5/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | IDH1 | O75874 | 1/20 | 0.43 |
| ▸ | CBS | P35520 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | ALPG | P10696 | 1/20 | 0.41 |
| ▸ | PRF1 | P14222 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8049363 | 1.00 | PTGS1 (0.54) | PTGS1PTGS2CTSBELANETOP1 | |
| SCHEMBL8050465 | 0.79 | PTGS1 (0.58) | PTGS1PTGS2CTSBELANETOP1 | |
| SCHEMBL8038648 | 0.79 | PTGS1 (0.58) | PTGS1PTGS2CTSBELANETOP1 | |
| SCHEMBL8049913 | 0.76 | PTP4A3 (0.66) | PTGS2MEN1KMT2AMAPTPOLB | |
| SCHEMBL8049909 | 0.76 | PTP4A3 (0.66) | PTGS2MEN1KMT2AMAPTPOLB | |
| SCHEMBL8038582 | 0.75 | MAPT (0.62) | PTGS1PTGS2CTSBELANETOP1 | |
| SCHEMBL8038584 | 0.75 | MAPT (0.62) | PTGS1PTGS2CTSBELANETOP1 | |
| SCHEMBL15421689 | 0.75 | PTGS1 (0.63) | PTGS1PTGS2CTSBELANETOP1 | |
| SCHEMBL15421688 | 0.75 | PTGS1 (0.63) | PTGS1PTGS2CTSBELANETOP1 | |
| SCHEMBL15421687 | 0.75 | PTGS1 (0.63) | PTGS1PTGS2CTSBELANETOP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6121303-A | SUCH AS 4-((3,4-DIHYDROXY-5-NITROPHENYL)METHYLIDENE)-2,5-IMIDAZOLIDINDIONE; MEDICINAL ANTIOXIDANTS FOR TREATMENT OR PREVENTION OF TISSUE DAMAGE CAUSED BY LIPID PEROXIDATION | ORION-YHTYMA OY (FI) | 2000-09-19 | — | — | US | claimed |
| EP-0526598-B1 | NEW PHARMACOLOGICALLY ACTIVE CATECHOL DERIVATIVES | ORION YHTYMAE OY (FI) | 1996-12-18 | — | — | EP | claimed |
| EP-0526598-A1 | NEW PHARMACOLOGICALLY ACTIVE CATECHOL DERIVATIVES. | ORION YHTYMAE OY (FI) | 1993-02-10 | — | — | EP | claimed |
| WO-1991017151-A1 | NEW PHARMACOLOGICALLY ACTIVE CATECHOL DERIVATIVES | Orion-Yhtymä Oy (FI) | 1991-11-14 | — | — | WO | claimed |
| US-6121303-A | SUCH AS 4-((3,4-DIHYDROXY-5-NITROPHENYL)METHYLIDENE)-2,5-IMIDAZOLIDINDIONE; MEDICINAL ANTIOXIDANTS FOR TREATMENT OR PREVENTION OF TISSUE DAMAGE CAUSED BY LIPID PEROXIDATION | ORION-YHTYMA OY (FI) | 2000-09-19 | — | — | US | disclosed |
| US-5889037-A | PREVENTION, THERAPY TISSUE DAMAGE FROM LIPID PEROXIDATION | ORION-YHTYMA OY (FI) | 1999-03-30 | — | — | US | disclosed |
| US-5614541-A | MEDICINAL ANTIOXIDANTS, REDUCING CELL DAMAGE CAUSED BY OXYGEN DERIVED RADICALS | Orion-yhtym a Oy (FI) | 1997-03-25 | — | — | US | disclosed |
| EP-0526598-B1 | NEW PHARMACOLOGICALLY ACTIVE CATECHOL DERIVATIVES | ORION YHTYMAE OY (FI) | 1996-12-18 | — | — | EP | disclosed |
| US-5362733-A | Lipid peroxidation prevention | ORION-YHTYMA OY (FI) | 1994-11-08 | — | — | US | disclosed |
| EP-0526598-A1 | NEW PHARMACOLOGICALLY ACTIVE CATECHOL DERIVATIVES. | ORION YHTYMAE OY (FI) | 1993-02-10 | — | — | EP | disclosed |
| WO-1991017151-A1 | NEW PHARMACOLOGICALLY ACTIVE CATECHOL DERIVATIVES | Orion-Yhtymä Oy (FI) | 1991-11-14 | — | — | WO | disclosed |